Washington Trust Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Washington Trust Bank's NVO Position: Q2 2019 in Review
Washington Trust Bank sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 600 shares — an estimated $16K sold.
Washington Trust Bank first reported a position in NVO in Q4 2013 and held it in 22 quarters. The position peaked at $576K in Q2 2015. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.
- Washington Trust Bank reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
- Washington Trust Bank sold 600 Novo Nordisk shares in Q2 2019, an estimated $16K.
- Washington Trust Bank first reported a position in Novo Nordisk in Q4 2013 and held it in 22 quarters.
- Washington Trust Bank's Novo Nordisk position peaked at $576K in Q2 2015.
- 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.
Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.